BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18002703)

  • 1. Predictive modeling in proteomics-based disease detection.
    Pham TD
    Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():3308-11. PubMed ID: 18002703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of proteomic data with multiclass Logistic Partial Least Squares algorithm.
    Liu Z; Chen D; Tian JP
    Int J Bioinform Res Appl; 2008; 4(1):1-10. PubMed ID: 18283025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hierarchical normalized cuts: unsupervised segmentation of vascular biomarkers from ovarian cancer tissue microarrays.
    Janowczyk A; Chandran S; Singh R; Sasaroli D; Coukos G; Feldman MD; Madabhushi A
    Med Image Comput Comput Assist Interv; 2009; 12(Pt 1):230-8. PubMed ID: 20425992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian cancer identification based on dimensionality reduction for high-throughput mass spectrometry data.
    Yu JS; Ongarello S; Fiedler R; Chen XW; Toffolo G; Cobelli C; Trajanoski Z
    Bioinformatics; 2005 May; 21(10):2200-9. PubMed ID: 15784749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Capillary electrophoresis coupled to mass spectrometry for proteome analysis. An innovative diagnostic method for prostate and bladder cancer].
    Wittke S; Schiffer E; Bauer HW
    Urologe A; 2007 Jul; 46(7):733-9. PubMed ID: 17318473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of HBV-associated HCC: insights on mechanisms of disease onset and biomarker discovery.
    Niu D; Feng H; Chen WN
    J Proteomics; 2010 May; 73(7):1283-90. PubMed ID: 20188222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the GA/KNN method to SELDI proteomics data.
    Li L; Umbach DM; Terry P; Taylor JA
    Bioinformatics; 2004 Jul; 20(10):1638-40. PubMed ID: 14962943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic biomarker identification for diagnosis of early relapse in ovarian cancer.
    Oh JH; Nandi A; Gurnani P; Knowles L; Schorge J; Rosenblatt KP; Gao JX
    J Bioinform Comput Biol; 2006 Dec; 4(6):1159-79. PubMed ID: 17245808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic profiling in ovarian cancer.
    Kim G; Minig L; Kohn EC
    Int J Gynecol Cancer; 2009 Dec; 19 Suppl 2(Suppl 2):S2-6. PubMed ID: 19955909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the analysis of glycomics mass spectrometry data via the regularized area under the ROC curve.
    Ye J; Liu H; Kirmiz C; Lebrilla CB; Rocke DM
    BMC Bioinformatics; 2007 Dec; 8():477. PubMed ID: 18076765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data.
    Wu B; Abbott T; Fishman D; McMurray W; Mor G; Stone K; Ward D; Williams K; Zhao H
    Bioinformatics; 2003 Sep; 19(13):1636-43. PubMed ID: 12967959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma proteomic pattern as biomarkers for ovarian cancer.
    Lin YW; Lin CY; Lai HC; Chiou JY; Chang CC; Yu MH; Chu TY
    Int J Gynecol Cancer; 2006; 16 Suppl 1():139-46. PubMed ID: 16515582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future for ovarian cancer screening: novel markers from emerging technologies of transcriptional profiling and proteomics.
    Mills GB; Bast RC; Srivastava S
    J Natl Cancer Inst; 2001 Oct; 93(19):1437-9. PubMed ID: 11584052
    [No Abstract]   [Full Text] [Related]  

  • 14. Discovery of significant rules for classifying cancer diagnosis data.
    Li J; Liu H; Ng SK; Wong L
    Bioinformatics; 2003 Oct; 19 Suppl 2():ii93-102. PubMed ID: 14534178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bagging linear sparse Bayesian learning models for variable selection in cancer diagnosis.
    Lu C; Devos A; Suykens JA; Arús C; Van Huffel S
    IEEE Trans Inf Technol Biomed; 2007 May; 11(3):338-47. PubMed ID: 17521084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoothing blemished gene expression microarray data via missing value imputation.
    Cai Z; Shi Y; Song M; Goebel R; Lin G
    Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():5688-91. PubMed ID: 19164008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-class cancer classification using multinomial probit regression with Bayesian gene selection.
    Zhou X; Wang X; Dougherty ER
    Syst Biol (Stevenage); 2006 Mar; 153(2):70-8. PubMed ID: 16986255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics.
    Poersch A; Grassi ML; Carvalho VP; Lanfredi GP; Palma CS; Greene LJ; de Sousa CB; Carrara HHA; Candido Dos Reis FJ; Faça VM
    J Proteomics; 2016 Aug; 145():226-236. PubMed ID: 27222041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer molecular pattern discovery by subspace consensus kernel classification.
    Han X
    Comput Syst Bioinformatics Conf; 2007; 6():55-65. PubMed ID: 17951812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regularized binormal ROC method in disease classification using microarray data.
    Ma S; Song X; Huang J
    BMC Bioinformatics; 2006 May; 7():253. PubMed ID: 16684357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.